SPX spenda limited

9.09%

0.6¢

Webinar questions, page-190

First 190 Last

Share
Profile

Follow
Merchant2000

24,969 Posts.

985

11/02/24

13:14

Post #: 72346109
Share

Originally posted by MustangMartos: ↑

It is fantastic to finally see both sides of the debate here. Investors offering some interesting and balanced opinions even those of you on the extremities. The reason most of us are here is because we could see a disruptive business that could be used across multiple industries and SCALE well beyond its market cap at the time.

After several years of questionable acquisitions, countless cap raising, rewards for an under performing and out of touch CEO, most longs here without the 'rose coloured glasses' are fed up.

That being said, we have finally landed some big name clients, have had Cap put some serious skin in the game and in my opinion, the core business has been somewhat proven effective and useful.

I think the next, and by far the most important peice of this ever growing and frustrating puzzle is, can this product and the team developing it effectively SCALE this thing to fit seamlessly in to different businesses and situations.

I think all of us who were brave/idiotic enough to put our money into the hands of a babbling, narcissistic, not so smooth talking CEO took the punt that this thing could eventually become a cross industry solution to B2B transactions. I do not have a financial or software background so I am forced to listen to various opinions and skim through webinars, deciphering buzz words to question if this thing has any credibility at the backend... Some big sised companies seem to think so.

All in all it has been a huge step forward signing deals with Ebev, Cap and CC. This has tempted me to average down but now after Agri being put on ice and listening to the latest webinar performance I can not be certain this thing can SCALE effectively and honestly wonder if every customer we attempt to integrate with will be a square peg in a round hole situation requiring ever eroding financial resources. To separate the wheat from the chaff my only question now is can this thing SCALE cost effectively into different nodes. Answered correctly I see CF+ and beyond if not I see Capital Raising to oblivion and siphoning of mum and dads hard earned.

Time will tell good luck to all of you tortured holders extra points if you have been insane enough to hold since the CRO times.

Expand

That being said, we have finally landed some big name clients, have had Cap put some serious skin in the game and in my opinion, the core business has been somewhat proven effective and useful.

Last CR $18m @ 9c 200m shares - by corner stone investor/s

Now CR $7m for nearly 600m shares and seat on board and who knows what fees are negotiated to Cap clients etc etc

Good Luck All IMO and DYOR on whether $7m is serious skin in the game lol

SPX Price at posting: 1.3¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

First 190 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.6¢		Change 0.001(9.09%)		Mkt cap ! $27.69M

Open	High	Low	Value	Volume
0.6¢	0.7¢	0.6¢	$23.32K	3.880M

Buyers (Bids)

No.	Vol.	Price($)
2	280696	0.6¢

Sellers (Offers)

Price($)	Vol.	No.
0.7¢	18216262	29

View Market Depth

No.	Vol.	Price($)
2	280696	0.006
48	22729523	0.005
8	15700000	0.004
9	26100000	0.003
5	17000002	0.002

Price($)	Vol.	No.
0.007	17544441	26
0.008	3921694	23
0.009	9234397	15
0.010	842781	5
0.011	527004	4

Last trade - 15.59pm 27/06/2025 (20 minute delay)

SPX (ASX) Chart

Webinar questions, page-190

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Webinar questions, page-190

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News